Indrayani Biotech Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
- Paid Up Capital ₹ 45.54 Cr
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 22.15 Cr
- Satisfied Charges ₹ 6.30 M
- Revenue Growth 4138.80%
- Profit Growth -5197.08%
- Ebitda -2904.63%
- Net Worth 2417.72%
- Total Assets 17962.93%
About Indrayani Biotech
Indrayani Biotech Limited (IBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 09 March 1992 and has a history of 32 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 526445.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 45.54 Cr.
The company currently has active open charges totaling ₹22.15 Cr. The company has closed loans amounting to ₹6.30 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indrayani Biotech Limited India are Vinayaka Bodala as CFO and Venkatraman Santhanakrishnan as Company Secretary. Singarababu Indirakumar, Muthukrishnan Ramesh, Kannimangalam Vaidyanathan, and Five other members serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L40100TN1992PLC129301
- Company No.
129301
- Stock Symbol
BSE : 526445
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Mar 1992
- Date of AGM
22 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Indrayani Biotech?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kasiraman Sundar ![]() | Managing Director | 17-Feb-2018 | Current |
Vinayaka Bodala | CFO | 04-Jan-2021 | Current |
Venkatraman Santhanakrishnan ![]() | Company Secretary | 31-Jan-2024 | Current |
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Muthukrishnan Ramesh ![]() | Whole-Time Director | 04-Jan-2021 | Current |
Singarababu Indirakumar ![]() | Whole-Time Director | 01-Aug-2020 | Current |
Kannimangalam Vaidyanathan ![]() | Director | 20-Aug-2018 | Current |
Swaminathan ![]() | Whole-Time Director | 01-Aug-2020 | Current |
Lakshmiprabha Kasiraman ![]() | Director | 20-Aug-2018 | Current |
Nangavaram Ranganathan ![]() | Director | 20-Aug-2018 | Current |
Financial Performance of Indrayani Biotech.
Indrayani Biotech Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 4138.8% increase. The company also saw a substantial fall in profitability, with a 5197.08% decrease in profit. The company's net worth Soared by an impressive increase of 2417.72%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indrayani Biotech?
In 2022, Indrayani Biotech had a promoter holding of 48.81% and a public holding of 51.19%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/overview/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹22.15 Cr
₹0.63 Cr
Charges Breakdown by Lending Institutions
- Others : 11.78 Cr
- Axis Bank Limited : 10.00 Cr
- Hdfc Bank Limited : 0.37 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
26 Feb 2024 | Hdfc Bank Limited | ₹3.70 M | Open |
21 Jan 2023 | Others | ₹7.00 Cr | Open |
08 Dec 2022 | Others | ₹1.90 M | Open |
16 Nov 2022 | Others | ₹0.86 M | Open |
26 Apr 2022 | Others | ₹1.60 M | Open |
How Many Employees Work at Indrayani Biotech?
Indrayani Biotech has a workforce of 445 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
![Graph showing employee growth trends](/Images/overview/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/overview/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Indrayani Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indrayani Biotech's trajectory.
Rating
![Graph displaying rating trends over time](/Images/overview/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/overview/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.